Granules gets FDA nod for Loratadine tablets


Hyderabad: Hyderabad-based pharmaceuticals company Granules India on Tuesday said the US health regulator USFDA has given its approval to the abbreviated new drug application (ANDA) filed by the drug firm for Loratadine tablets used to treat allergies.

“The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd, for Loratadine tablets USP, 10 mg (OTC),” the company said in a BSE filing.

The approved ANDA is the bioequivalent to the Reference Listed Drug (RLD), Claritin tablets 10 mg by Bayer HealthCare LLC, the company said. The company further said that it intends to commercialise this product “shortly”.

Now you can get handpicked stories from Telangana Today on WhatsApp / Telegram everyday. Click these links to subscribe and save this number 9182563636 on your contacts.